USPTO serial 79437912
LACB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 6, 2026
- Examiner
- CROWDER-SCHAEFER, ANDREW W
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LACB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Erica Halstead
Erica Halstead Womble Bond Dickinson (US) LLP888 Seventh Ave.New York, NY 10106United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders; pharmaceutical preparations for the treatment of glaucoma and ocular hypertension; pharmaceutical preparations for the treatment of corneal endothelial disorder; sanitary preparations for medical use; pharmaceutical preparations for the treatment of conditions and diseases of the circulatory system; pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; hand-sanitizing preparations; antimicrobials for dermatologic use; disinfectants for sanitary purposes; household disinfectants; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital and anal conditions; pharmaceutical preparations, namely, amino acid for medical or veterinary purposes; pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system; topical and oral antibiotics; pharmaceutical preparations for use in chemotherapy; chemotherapeutic agents having antineoplastic activity; crude drugs, namely, medicinal herbs made of rootstock, bark, leaves, fruits, seeds, musk and bear's gall, used for the treatment of pain, cold, fever, anemia, and for diuretics and astringents; antibiotic preparations for human use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain; analgesics; dietary supplements for human beings; live biotherapeutic product in the nature of living cells for medical purposes; biological preparations for medical purposes, namely probiotic preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 6, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 18, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 18, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 13, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 12, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 29, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 29, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 20, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 15, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 15, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 15, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 5, 2026 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Feb 19, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 31, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 31, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 3, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 2, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 17, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 16, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 16, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 15, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 27, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |